Citizens JMP lowered the firm’s price target on Affirm (AFRM) to $75 from $85 and keeps an Outperform rating on the shares. Material volume upside only resulted in in-line revenue and modest operating income upside, the analyst tells investors in a research note. Affirm is a long-term secular winner at the expense primarily of the credit card industry, and is well-positioned to capitalize on continued buy-now-pay-later adoption for everyday purchases and benefits from a more robust loan platform relative to competitors, the firm contends.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFRM:
- Affirm Holdings Reports Strong Growth in Q3 2025
- Affirm Holdings: Strong Financial Health and Strategic Positioning Justify Buy Rating
- Affirm Holdings: Positioned for Long-Term Growth in the BNPL Market Despite Short-Term Challenges
- Closing Bell Movers: Pinterest jumps 15%, Toast up 7% after earnings
- Affirm reports Q3 operating income $173.7M vs. $78.5M last year